Less than six months after Nasdaq debut, Malaysia’s Alps Group pivots to bridge biotech access gap Read More » April 20, 2026
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight Read More » April 17, 2026
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Read More » February 24, 2026
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy Read More » February 9, 2026
